Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision in the page footer updated from v3.6.5 to v3.6.6, indicating a site software update. No change to the study content or user-facing information is introduced by this update.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor page update or release; the study details appear unchanged.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page revision label changed from v3.6.3 to v3.6.4, signaling a new build was applied to the page.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a platform update. No study information or content on the page is changed.SummaryDifference0.1%

- Check78 days agoChange DetectedThe revision note now shows v3.6.2, replacing the previous v3.6.0. This indicates a new site release/version update rather than a substantive change to page content.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page lists Masatoshi Kudo as the investigator (without the institution) and introduces Last verified metadata, while adding help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updating the revision from v3.5.5 to v3.6.0.SummaryDifference2%

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.